Design of Multivariate PID Controller for Power Networks Using GEA and PSO

The issue of proper modeling and control for industrial systems is one of the challenging issues in the industry. In addition, in recent years, PID controller design for linear systems has been widely considered. The topic discussed in some of the articles is mostly speed control in the field of electric machines, where various algorithms have been used to optimize the considered controller, and always one of the most important challenges in this field is designing a controller with a high degree of freedom. In these researches, the focus is more on searching for an algorithm with more optimal results than others in order to estimate the parameters in a more appropriate way. There are many techniques for designing a PID controller. Among these methods, meta-innovative methods have been widely studied. In addition, the effectiveness of these methods in controlling systems has been proven. In this paper, a new method for grid control is discussed. In this method, the PID controller is used to control the power systems, which can be controlled more effectively, so that this controller has four parameters, and to determine these parameters, the optimization method and evolutionary algorithms of genetics (EGA) and PSO are used.  One of the most important advantages of these algorithms is their high speed and accuracy. In this article, these algorithms have been tested on a single-machine system, so that the single-machine system model is presented first, then the PID controller components will be examined. In the following, according to the transformation function matrix and the relative gain matrix, suitable inputs for each of the outputs are determined. At the end, an algorithm for designing PID controller for multivariable MIMO systems is presented. To show the effectiveness of the proposed controller, a simulation was performed in the MATLAB environment and the results of the simulations show the effectiveness of the proposed controller

RESULTS AND CHALLENGES OF ARTIFICIAL NEURAL NETWORKS USED FOR DECISION-MAKING AND CONTROL IN MEDICAL APPLICATIONS

The aim of this paper is to present several approaches by which technology can assist medical decision-making. This is an essential, but also a difficult activity, which implies a large number of medical and technical aspects. But, more important, it involves humans: on the one hand, the patient, who has a medical problem and who requires the best solution; on the other hand, the physician, who should be able to provide, in any circumstances, a decision or a prediction regarding the current and the future medical status of the patient. The technology, in general, and particularly the Artificial Intelligence (AI) tools could help both of them, and it is assisted by appropriate theory regarding modeling tools. One of the most powerful mechanisms that can be used in this field is the Artificial Neural Networks (ANNs). This paper presents some of the results obtained by the Process Control group of the Politehnica University Timisoara, Romania, in the field of ANNs applied to modeling, prediction and decision-making related to medical systems. An Iterative Learning Control-based approach to batch training a feedforward ANN architecture is given. The paper includes authors’ concerns in this domain and emphasizes that these intelligent models, even if they are artificial, are able to make decisions, being useful tools for prevention, early detection and personalized healthcare

A local glucose-and oxygen concentration-based insulin secretion model for pancreatic islets

<p>Abstract</p> <p>Background</p> <p>Because insulin is the main regulator of glucose homeostasis, quantitative models describing the dynamics of glucose-induced insulin secretion are of obvious interest. Here, a computational model is introduced that focuses not on organism-level concentrations, but on the quantitative modeling of local, cellular-level glucose-insulin dynamics by incorporating the detailed spatial distribution of the concentrations of interest within isolated avascular pancreatic islets.</p> <p>Methods</p> <p>All nutrient consumption and hormone release rates were assumed to follow Hill-type sigmoid dependences on local concentrations. Insulin secretion rates depend on both the glucose concentration and its time-gradient, resulting in second-and first-phase responses, respectively. Since hypoxia may also be an important limiting factor in avascular islets, oxygen and cell viability considerations were also built in by incorporating and extending our previous islet cell oxygen consumption model. A finite element method (FEM) framework is used to combine reactive rates with mass transport by convection and diffusion as well as fluid-mechanics.</p> <p>Results</p> <p>The model was calibrated using experimental results from dynamic glucose-stimulated insulin release (GSIR) perifusion studies with isolated islets. Further optimization is still needed, but calculated insulin responses to stepwise increments in the incoming glucose concentration are in good agreement with existing experimental insulin release data characterizing glucose and oxygen dependence. The model makes possible the detailed description of the intraislet spatial distributions of insulin, glucose, and oxygen levels. In agreement with recent observations, modeling also suggests that smaller islets perform better when transplanted and/or encapsulated.</p> <p>Conclusions</p> <p>An insulin secretion model was implemented by coupling local consumption and release rates to calculations of the spatial distributions of all species of interest. The resulting glucose-insulin control system fits in the general framework of a sigmoid proportional-integral-derivative controller, a generalized PID controller, more suitable for biological systems, which are always nonlinear due to the maximum response being limited. Because of the general framework of the implementation, simulations can be carried out for arbitrary geometries including cultured, perifused, transplanted, and encapsulated islets.</p

Closed-loop Prevention of Hypotension in the Heartbeating Brain-dead Porcine Model

Objective: The purpose of this paper is to demonstrate feasibility of a novel closed-loop controlled therapy for prevention of hypertension in the heartbeating brain-dead porcine model. Methods: Dynamic modeling and system identification were based on in-vivo data. A robust controller design was obtained for the identified models. Disturbance attenuation properties, and reliability of operation of the resulting control system, were evaluated in vivo. Results: The control system responded both predictably and consistently to external disturbances. It was possible to prevent mean arterial pressure to fall below a user-specified reference throughout 24 h of completely autonomous operation.Conclusion: Parameter variability in the identified models confirmed the benefit of closed-loop controlled administration of the proposed therapy. The evaluated robust controller was able to mitigate both process uncertainty and external disturbances. Significance: Prevention of hypertension is critical to the care of heartbeating brain-dead organ donors. Its automation would likely increase the fraction of organs suitable for transplantation from this patient group

Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes

Background: Patients with Type 1 Diabetes (T1D) are particularly vulnerable to development of Diabetic nephropathy (DN) leading to End Stage Renal Disease. Hence a better understanding of the factors affecting kidney disease progression in T1D is urgently needed. In recent years microRNAs have emerged as important post-transcriptional regulators of gene expression in many different health conditions. We hypothesized that urinary microRNA profile of patients will differ in the different stages of diabetic renal disease. Methods and Findings: We studied urine microRNA profiles with qPCR in 40 T1D with >20 year follow up 10 who never developed renal disease (N) matched against 10 patients who went on to develop overt nephropathy (DN), 10 patients with intermittent microalbuminuria (IMA) matched against 10 patients with persistent (PMA) microalbuminuria. A Bayesian procedure was used to normalize and convert raw signals to expression ratios. We applied formal statistical techniques to translate fold changes to profiles of microRNA targets which were then used to make inferences about biological pathways in the Gene Ontology and REACTOME structured vocabularies. A total of 27 microRNAs were found to be present at significantly different levels in different stages of untreated nephropathy. These microRNAs mapped to overlapping pathways pertaining to growth factor signaling and renal fibrosis known to be targeted in diabetic kidney disease. Conclusions: Urinary microRNA profiles differ across the different stages of diabetic nephropathy. Previous work using experimental, clinical chemistry or biopsy samples has demonstrated differential expression of many of these microRNAs in a variety of chronic renal conditions and diabetes. Combining expression ratios of microRNAs with formal inferences about their predicted mRNA targets and associated biological pathways may yield useful markers for early diagnosis and risk stratification of DN in T1D by inferring the alteration of renal molecular processes. © 2013 Argyropoulos et al

Perfusion bioreactor for liver bioengineering

End-stage organ failure has grown to become one of the key challenges for the medical community because of the high number of patients in waiting list for a transplant and the severe shortage of suitable organ donors. These, together with population ageing, have created an accumulation phenomenon of patients which increases the severity of the problem. New techniques for organ preservation, organ recovery from organs not suitable for transplant, and organ recellularization attempt to tackle this problem, appearing as some of the most promising solutions. The aim of this bachelor thesis is to continue the development of a complex liver perfusion bioreactor in order to design and develop an efficient and repeatable method for organ perfusion, decellularization and recellularization, with the final objective being the creation of a perfusion bioreactor for liver bioengineering able to be used for organ perfusion and preservation, organ decellularization and organ recellularization, able to preserve cell structure, functionality, growth and control differentiation for up to 4 weeks, while avoiding contamination and automating as much as possible the process. In order to do this, the bioreactor will include many sensors and data acquisition systems as well as control systems for pressure, flow rate, and temperature among others.Ingeniería Biomédic